Summary & Overview
HCPCS C9777: Esophageal Mucosal Integrity Testing by Electrical Impedance
HCPCS Level II code C9777 designates esophageal mucosal integrity testing by electrical impedance performed transorally and including esophagoscopy or esophagogastroduodenoscopy. This specialized diagnostic procedure provides objective assessment of esophageal mucosal integrity, which has implications for evaluating gastroesophageal reflux disease and other mucosal disorders. Nationally, accurate coding for emerging diagnostic modalities like impedance testing influences coverage determinations, claims processing, and comparative utilization reporting.
Key payers addressed in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find contextual clinical description, common payer coverage considerations, and benchmarking content where available. The publication summarizes typical sites of service, common modifiers used with the code, and operational implications for ambulatory endoscopy suites and hospital-based endoscopy units. It also outlines what to look for in payer policies and prior authorization criteria and identifies gaps where specific payer guidance or national consensus is not yet available.
This summary is intended to orient clinicians, coding professionals, and policy analysts to the clinical purpose and billing context of C9777, clarifying where to focus further review of individual payer policies and clinical documentation practices.
Billing Code Overview
HCPCS Level II code C9777 describes esophageal mucosal integrity testing by electrical impedance, transoral. The procedure is performed transorally and includes esophagoscopy or esophagogastroduodenoscopy as part of the service. This test assesses the integrity of the esophageal mucosa using electrical impedance measurements during an endoscopic approach.
Service type: Diagnostic esophageal mucosal integrity testing by electrical impedance via transoral endoscopic technique.
Typical site of service: Endoscopy suite or operating room during an esophagoscopy or esophagogastroduodenoscopy.
Clinical & Coding Specifications
Clinical Context
A 52-year-old patient with chronic heartburn, regurgitation, and intermittent chest pain is referred to gastroenterology after incomplete response to proton pump inhibitor therapy. Prior noninvasive testing and upper endoscopy show no clear mucosal ulceration, but symptoms suggest gastroesophageal reflux disease (GERD) with possible esophageal hypersensitivity or nonerosive reflux disease. The patient undergoes esophageal mucosal integrity testing by electrical impedance performed transorally during the same session as diagnostic esophagogastroduodenoscopy (EGD) to evaluate baseline mucosal integrity and detect increased permeability associated with reflux disease. The clinical workflow includes preprocedure history and consent, conscious sedation or monitored anesthesia care per institutional protocol, diagnostic EGD to assess mucosa, placement of the impedance probe transorally to record mucosal impedance measurements, documentation of findings in the operative report, and recovery with postprocedure discharge instructions. Documentation should link the indication (for example, persistent reflux symptoms, suspected refractory GERD, or nonerosive reflux disease) to the procedure and record device used, measurement sites, technical success, and any complications.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier used | Use when no special modifiers apply; standard reporting. |